Vanessa Klapp

rue Nicolas-Ernest Barblé, 6
1210 Luxembourg
Luxembourg

43

Citations

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Vanessa Klapp is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

1 Active

I2TRON Vanessa Klapp: Immunotherapies and drug screening in improved patient-derived models: a translational approach towards personalized treatments for leukaemia
Paggetti, J., Klapp, V. & Moussay, E.
FNR - Fonds National de la Recherche
1/09/22 → 30/08/26
Project: Research

5 Chapter
5 Article
4 Review article
2 Meeting Abstract
More
- 1 Short survey

Cellular senescence in the response of HR⁺ breast cancer to radiotherapy and CDK4/6 inhibitors
Klapp, V., Buqué, A., Bloy, N., Sato, A., Yamazaki, T., Zhou, X. K., Formenti, S. C., Galluzzi, L. & Petroni, G., 10 Feb 2023, In: Journal of Translational Medicine. 21, 1, p. 110 1 p.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
Flow cytometry-assisted quantification of cell cycle arrest in cancer cells treated with CDK4/6 inhibitors
Klapp, V., Bloy, N., Jiménez-Cortegana, C., Buqué, A. & Petroni, G., 22 Aug 2023, (Accepted/In press) In: Methods in Cell Biology.
Research output: Contribution to journal › Article › Research › peer-review
Immunologically relevant effects of radiation therapy on the tumor microenvironment
Galassi, C., Klapp, V., Formenti, S. C., Demaria, S. & Galluzzi, L., 18 May 2023, (E-pub ahead of print) In: Essays in Biochemistry. EBC20220248.
Research output: Contribution to journal › Article › Research › peer-review
Inhibition of MYC translation through targeting of the newly identified PHB-eIF4F complex as a therapeutic strategy in CLL
Largeot, A., Klapp, V., Viry, E., Gonder, S., Fernandez Botana, I., Blomme, A., Benzarti, M., Pierson, S., Duculty, C., Marttila, P., Wierz, M., Gargiulo, E., Pagano, G., An, N., El Hachem, N., Perez Hernandez, D., Chakraborty, S., Ysebaert, L., François, J. H., Cortez Clemente, S., & 13 othersBerchem, G., Efremov, D. G., Dittmar, G., Szpakowska, M., Chevigné, A., Nazarov, P. V., Helleday, T., Close, P., Meiser, J., Stamatopoulos, B., Désaubry, L., Paggetti, J. & Moussay, E., 29 Jun 2023, In: Blood. 141, 26, p. 3166-3183 18 p.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
1 Citation (Scopus)
Inhibition of MYC translation through targeting of the newly identified PHB-EIF4F complex as therapeutic strategy inchronic lymphocytic leukemia (CLL)
Largeot, A., Klapp, V., Viry, E., Gonder, S., Botana, I. F., Blomme, A., Benzarti, M., Pierson, S., Duculty, C., Marttila, P., Wierz, M., Gargiulo, E., Pagano, G., An, N., El Hachem, N., Perez Hernandez, D., Chakraborty, S., Ysebaert, L., François, J-H., Cortez, S., & 13 othersBerchem, G., Efremov, D. G., Dittmar, G., Szpakowska, M., Chevigne, A., Nazarov, P. V., Helleday, T., Close, P., Meiser, J., Stamatopoulos, B., Désaubry, L., Paggetti, J. & Moussay, E., Aug 2023, In: HemaSphere. 7, S3, S141.
Research output: Contribution to journal › Meeting Abstract › peer-review

Open Access

Vanessa Klapp

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

I2TRON Vanessa Klapp: Immunotherapies and drug screening in improved patient-derived models: a translational approach towards personalized treatments for leukaemia

Cellular senescence in the response of HR⁺ breast cancer to radiotherapy and CDK4/6 inhibitors

Flow cytometry-assisted quantification of cell cycle arrest in cancer cells treated with CDK4/6 inhibitors

Immunologically relevant effects of radiation therapy on the tumor microenvironment

Inhibition of MYC translation through targeting of the newly identified PHB-eIF4F complex as a therapeutic strategy in CLL

Inhibition of MYC translation through targeting of the newly identified PHB-EIF4F complex as therapeutic strategy inchronic lymphocytic leukemia (CLL)

Vanessa Klapp

Fingerprint

Collaborations and top research areas from the last five years

Projects

I2TRON Vanessa Klapp: Immunotherapies and drug screening in improved patient-derived models: a translational approach towards personalized treatments for leukaemia

Research output

Cellular senescence in the response of HR+ breast cancer to radiotherapy and CDK4/6 inhibitors

Flow cytometry-assisted quantification of cell cycle arrest in cancer cells treated with CDK4/6 inhibitors

Immunologically relevant effects of radiation therapy on the tumor microenvironment

Inhibition of MYC translation through targeting of the newly identified PHB-eIF4F complex as a therapeutic strategy in CLL

Inhibition of MYC translation through targeting of the newly identified PHB-EIF4F complex as therapeutic strategy inchronic lymphocytic leukemia (CLL)

Cellular senescence in the response of HR⁺ breast cancer to radiotherapy and CDK4/6 inhibitors